全文获取类型
收费全文 | 613篇 |
免费 | 99篇 |
专业分类
712篇 |
出版年
2018年 | 6篇 |
2016年 | 12篇 |
2015年 | 11篇 |
2014年 | 13篇 |
2013年 | 33篇 |
2012年 | 16篇 |
2011年 | 13篇 |
2010年 | 9篇 |
2009年 | 19篇 |
2008年 | 21篇 |
2007年 | 23篇 |
2006年 | 19篇 |
2005年 | 24篇 |
2004年 | 16篇 |
2003年 | 15篇 |
2002年 | 23篇 |
2001年 | 18篇 |
2000年 | 23篇 |
1999年 | 26篇 |
1998年 | 19篇 |
1997年 | 7篇 |
1996年 | 10篇 |
1995年 | 8篇 |
1994年 | 10篇 |
1993年 | 14篇 |
1992年 | 10篇 |
1991年 | 14篇 |
1990年 | 15篇 |
1989年 | 22篇 |
1988年 | 21篇 |
1987年 | 10篇 |
1986年 | 17篇 |
1985年 | 17篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1982年 | 9篇 |
1980年 | 5篇 |
1979年 | 12篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1975年 | 8篇 |
1973年 | 7篇 |
1972年 | 7篇 |
1971年 | 5篇 |
1969年 | 6篇 |
1968年 | 5篇 |
1967年 | 6篇 |
1966年 | 6篇 |
1961年 | 5篇 |
1960年 | 5篇 |
排序方式: 共有712条查询结果,搜索用时 0 毫秒
21.
OBJECTIVES: To characterize the extent of delay in administration of thrombolytic therapy to patients with acute myocardial infarction (AMI) in Canada, to examine patient-specific predictors of such delay and to measure the effect of delay on short-term nonfatal cardiac outcomes. DESIGN: Secondary cohort analysis of data from the first international Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) trial. SETTING: Sixty-three acute care hospitals across Canada. SUBJECTS: All 2898 Canadian patients with an AMI enrolled in GUSTO-I. MAIN OUTCOMES: Time before arrival at a hospital ("symptom-to-door" time) and time from arrival to administration of therapy ("door-to-needle" time) for patients who had an AMI outside of a hospital, in clinically relevant categories; proportions of patients with nonfatal, serious cardiac events, including shock, sustained ventricular tachycardia, ventricular fibrillation and asystole. RESULTS: Of the total number of patients enrolled, records were complete for 2708; 2542 of these patients (93.9%) had an AMI outside of a hospital. These 2542 patients presented a median 81 (interquartile range 50 to 130) minutes after the onset of symptoms, and the median time to treatment in hospital was 85 (interquartile range 61 to 115) minutes. Whereas a greater proportion of Canadian patients than of patients enrolled in GUSTO-I in other countries reached hospital within 2 hours of symptom onset (71.5% v. 61.2%, p < 0.001), a greater proportion of Canadian patients experienced in-hospital treatment delays of more than 1 hour (75.3% v. 57.1%, p < 0.001). In an analysis of all 2708 patients with complete records, both the unadjusted and adjusted odds of nonfatal cardiac events for those treated 4 to 6 hours after symptom onset were significantly higher than for those treated within 2 hours (odds ratio 1.60, 95% confidence interval 1.09 to 2.37). CONCLUSION: After arrival at a hospital, Canadian patients enrolled in GUSTO-I received thrombolytic therapy more slowly than trial enrollees in other countries. Such delays are already known to decrease the rate of short-term survival after AMI. The findings further show that long time to treatment also increases the odds of nonfatal, serious cardiac events. Hospitals and physicians caring for patients with AMI should routinely assess whether and how they can improve door-to-needle times. 相似文献
22.
Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation 下载免费PDF全文
Zhou J Chehab R Tkalcevic J Naylor MJ Harris J Wilson TJ Tsao S Tellis I Zavarsek S Xu D Lapinskas EJ Visvader J Lindeman GJ Thomas R Ormandy CJ Hertzog PJ Kola I Pritchard MA 《The EMBO journal》2005,24(3):635-644
Elf5 is an epithelial-specific ETS factor. Embryos with a null mutation in the Elf5 gene died before embryonic day 7.5, indicating that Elf5 is essential during mouse embryogenesis. Elf5 is also required for proliferation and differentiation of mouse mammary alveolar epithelial cells during pregnancy and lactation. The loss of one functional allele led to complete developmental arrest of the mammary gland in pregnant Elf5 heterozygous mice. A quantitative mRNA expression study and Western blot analysis revealed that decreased expression of Elf5 correlated with the downregulation of milk proteins in Elf5(+/-) mammary glands. Mammary gland transplants into Rag(-/-) mice demonstrated that Elf5(+/-) mammary alveolar buds failed to develop in an Elf5(+/+) mammary fat pad during pregnancy, demonstrating an epithelial cell autonomous defect. Elf5 expression was reduced in Prolactin receptor (Prlr) heterozygous mammary glands, which phenocopy Elf5(+/-) glands, suggesting that Elf5 and Prlr are in the same pathway. Our data demonstrate that Elf5 is essential for developmental processes in the embryo and in the mammary gland during pregnancy. 相似文献
23.
Chilling-enhanced photooxidation : evidence for the role of singlet oxygen and superoxide in the breakdown of pigments and endogenous antioxidants 总被引:22,自引:12,他引:22 下载免费PDF全文
Chilling temperatures (5°C) and high irradiance (1000 microeinsteins per square meter per second) were used to induce photooxidation in detached leaves of cucumber (Cucumis sativus L.), a chilling-sensitive plant. Chlorophyll a, chlorophyll b, β carotene, and three xanthophylls were degraded in a light-dependent fashion at essentially the same rate. Lipid peroxidation (measured as ethane evolution) showed an O2 dependency. The levels of three endogenous antioxidants, ascorbate, reduced glutathione, and α tocopherol, all showed an irradiance-dependent decline. α-Tocopherol was the first antioxidant affected and appeared to be the only antioxidant that could be implicated in long-term protection of the photosynthetic pigments. Results from the application of antioxidants having relative selectivity for 1O2, O2−, or OH indicated that both 1O2 and O2− were involved in the chilling- and light-induced lipid peroxidation which accompanied photooxidation. Application of D2O (which enhances the lifetime of 1O2) corroborated these results. Chilling under high light produced no evidence of photooxidative damage in detached leaves of chilling-resistant pea (Pisum sativum L.). Our results suggest a fundamental difference in the ability of pea to reduce the destructive effects of free-radical and 1O2 production in chloroplasts during chilling in high light. 相似文献
24.
Whether ultimately utilized as retinoic acid, retinal, or retinol, vitamin A is transported to the target cells as all-trans-retinol bound to retinol-binding protein (RBP). Circulating in the plasma, RBP itself is bound to transthyretin (TTR, previously referred to as thyroxine-binding prealbumin). In vitro one tetramer of TTR can bind two molecules of retinol-binding protein. However, the concentration of RBP in the plasma is limiting, and the complex isolated from serum is composed of TTR and RBP in a 1 to 1 stoichiometry. We report here the crystallographic structure at 3.2 A of the protein-protein complex of human RBP and TTR. RBP binds at a 2-fold axis of symmetry in the TTR tetramer, and consequently the recognition site itself has 2-fold symmetry: Four TTR amino acids (Arg-21, Val-20, Leu-82, and Ile-84) are contributed by two monomers. Amino acids Trp-67, Phe-96, and Leu-63 and -97 from RBP are flanked by the symmetry-related side chains from TTR. In addition, the structure reveals an interaction of the carboxy terminus of RBP at the protein-protein recognition interface. This interaction, which involves Leu-182 and Leu-183 of RBP, is consistent with the observation that naturally occurring truncated forms of the protein are more readily cleared from plasma than full-length RBP. Complex formation prevents extensive loss of RBP through glomerular filtration, and the loss of Leu-182 and Leu-183 would result in a decreased affinity of RBP for TTR. 相似文献
25.
26.
27.
28.
29.
30.